[{"id":"c9c6e440-cde3-4057-95c9-d745f83e256c","acronym":"","url":"https://clinicaltrials.gov/study/NCT01867424","created_at":"2021-01-18T08:21:19.546Z","updated_at":"2024-07-02T16:36:43.481Z","phase":"Phase 2","brief_title":"Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer","source_id_and_acronym":"NCT01867424","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" SLCO1B3","pipe":" | ","alterations":" SLCO1B3 expression","tags":["SLCO1B3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SLCO1B3 expression"],"overall_status":"Completed","enrollment":" Enrollment 24","initiation":"Initiation: 05/14/2013","start_date":" 05/14/2013","primary_txt":" Primary completion: 05/30/2016","primary_completion_date":" 05/30/2016","study_txt":" Completion: 12/08/2016","study_completion_date":" 12/08/2016","last_update_posted":"2020-07-08"},{"id":"8faef309-098a-4e8d-a4ac-db5d6f0872eb","acronym":"","url":"https://clinicaltrials.gov/study/NCT03960788","created_at":"2021-01-18T19:29:25.682Z","updated_at":"2024-07-02T16:36:59.333Z","phase":"Phase 1","brief_title":"Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer","source_id_and_acronym":"NCT03960788","lead_sponsor":"University of Cincinnati","biomarkers":" SLCO1B3","pipe":" | ","alterations":" SLCO1B3 expression","tags":["SLCO1B3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SLCO1B3 expression"],"overall_status":"Unknown status","enrollment":" Enrollment 50","initiation":"Initiation: 01/02/2018","start_date":" 01/02/2018","primary_txt":" Primary completion: 01/02/2020","primary_completion_date":" 01/02/2020","study_txt":" Completion: 01/02/2021","study_completion_date":" 01/02/2021","last_update_posted":"2019-05-23"}]